Volift and Volbella are two of the latest hyaluronic acid fillers to know about! Both of which are still in clinical trials in the U.S. and not yet FDA-approved, but are currently being used in Europe where they’re showing promising results.
New York facial plastic surgeon Dilip Madnani stated “Volift is supposed to last much longer than the fillers Allergan [the parent company] currently has. It’s a medium consistency, so can be injected more superficially than Voluma, and would be used similar to how Juvederm is currently used. Ideal candidates for Volift are those who have mild to moderate depressions on their face, such as nasolabial folds and marionette lines. The filler is supposed to last up to 15 months.”
Volbella is also gaining anticipation stateside. “Volbella is a thinner consistency and can be used even more superficially than Volift,” says Dr. Madnani. “Ideal candidates will be anyone who has these lines and wants them corrected quickly without much downtime. It is supposed to last up to 12 months.” Dr. Madfes says Volbella best targets fine lines on the skin’s surface, such as “smoker’s lines” on the upper lip.”
We’re hoping to see these new products hit doctors’ offices stateside in late 2016, but at this point, it’s in the hands of the FDA.
Leave a Reply